T7 Endonuclease I (T7E1) Mismatch Cleavage Assay for Rapid Estimation of CRISPR Indel Frequency

Edited bulk population versus unedited parental control, each in duplicate PCR reactions. Amplicon designed 400-800 bp with the cut site placed asymmetrically (~1/3 from one end) so cleavage yields two clearly resolvable fragments of distinct sizes. Each T7E1 reaction includes a paired no-enzyme control (same amplicon, no T7E1) to distinguish true cleavage from nonspecific bands. Densitometry on all lanes; readout same day as harvest.

BSL-2 if working from human-cell-derived gDNA; purified gDNA is low-risk. Standard PPE (gloves, lab coat, eye protection). DNA stains: GelRed/SYBR Safe are lower-hazard alternatives to ethidium bromide but still treat as potential mutagens and use a dedicated gel area; dispose of stained gels as chemical waste. UV transilluminator: wear a UV face shield. Maintain pre-/post-PCR separation to avoid amplicon contamination. No special biohazard beyond cell-line gDNA.

Unedited parental amplicon processed identically (denatured/re-annealed + T7E1) is the essential negative control — it must show no cleavage; any background cleavage defines the assay floor. No-enzyme control per sample distinguishes T7E1 cleavage from PCR artifacts/nonspecific bands. A previously validated edited sample serves as a positive control confirming T7E1 lot activity and heteroduplex formation. A SNP-free, single-band amplicon is required (a heterozygous SNP in the unedited control causes false cleavage).

Active sgRNA: visible cleavage products at the two expected fragment sizes (summing to the full-length amplicon), with estimated indel frequency typically 10-60%. Unedited control: a single uncleaved full-length band with no cleavage products. T7E1 is semi-quantitative and saturates above ~40-50% editing; estimates should be treated as approximate and confirmed by sequencing for precise values. Detection limit ~3-5% indels.

• Genomic DNA from edited and unedited cells, 50-100 ng/µL
• High-fidelity polymerase (NEB Q5 Hot Start 2X Master Mix M0494) — proofreading enzyme required for clean heteroduplex formation
• Locus-specific primers flanking the cut site, amplicon 400-800 bp with asymmetric cut placement
• T7 Endonuclease I (NEB M0302), 10 U/µL
• NEBuffer 2 (10X)
• 0.5 M EDTA (stop solution)
• DNA purification (QIAquick PCR Purification or AMPure XP)
• Agarose (2% for resolution) + 1X TBE, or a TapeStation/Fragment Analyzer for capillary quantification
• SYBR Safe or GelRed DNA stain
• 100 bp DNA ladder

Amplify a CRISPR target locus from edited and control cell populations, form heteroduplexes by denaturation/re-annealing, cleave mismatched DNA with T7 Endonuclease I, and estimate indel frequency from cleaved-versus-uncleaved band intensities on an agarose or capillary gel as a rapid screen of sgRNA activity.

1. PCR-amplify the target locus: 50-100 ng gDNA, 0.5 µM each primer, Q5 2X MM, 25 µL; 98 C 30 s; 30-35 cycles 98 C 10 s / 62 C 20 s / 72 C 30 s; 72 C 2 min.
2. Verify a single clean band on a 1% agarose check gel; purify the amplicon; quantify.
3. Heteroduplex formation: combine 200 ng purified amplicon + 2 µL NEBuffer 2 + water to 19 µL.
4. Denature/re-anneal in a thermal cycler: 95 C 5 min; ramp to 85 C at -2 C/s; ramp 85 C to 25 C at -0.1 C/s; hold 4 C.
5. Add 1 µL (10 U) T7 Endonuclease I; incubate 37 C for 30 min (set up a parallel no-enzyme tube).
6. Stop with 1.5 µL 0.5 M EDTA.
7. Resolve on a 2% agarose/TBE gel (90 V, 60 min) or load on a Fragment Analyzer.
8. Image and densitometrically quantify uncleaved (parental) and cleaved fragment bands.

Independent variable: editing status of the input gDNA (edited vs unedited). Dependent variable: estimated indel frequency from band-intensity ratio. Controlled variables: input amplicon mass (200 ng), T7E1 units (10 U) and digestion time (30 min, 37 C), re-anneal ramp rates, amplicon design and primer set, gel percentage/run conditions, polymerase (proofreading), PCR cycle number.

An active sgRNA-Cas9 will generate sufficient indel heterogeneity that T7E1 cleavage produces visible cleavage products at the expected fragment sizes, yielding an estimated indel frequency that tracks (within ~10-15% absolute) the true frequency measured by amplicon sequencing, while unedited controls show no cleavage.

Quantify band intensities in ImageJ (Fiji) or the Fragment Analyzer software. Calculate indel frequency as: %indel = 100 x (1 - sqrt(1 - fcut)), where fcut = (sum of cleaved band intensities) / (cleaved + uncleaved intensities). Subtract any background cleavage seen in the unedited control. Report as an estimate and flag values >40% as likely underestimates due to T7E1 saturation. Use the no-enzyme lane to exclude nonspecific bands from quantification.

Cleavage in the unedited control (false positive): a heterozygous SNP in the amplicon — redesign primers to a SNP-free region or sequence the parental locus first. No cleavage despite known editing: incomplete heteroduplex formation — verify the slow re-anneal ramp and use a proofreading polymerase (Taq leaves artifacts). Smeary/multiple PCR bands: nonspecific amplification — raise anneal temperature, redesign primers, gel-purify the target band before digestion. Underestimated high-editing samples: T7E1 saturation above ~40% — dilute interpretation and confirm by amplicon-seq. Weak overall signal: too little amplicon loaded — increase input to 200-400 ng and confirm T7E1 activity with the positive control.

Report estimated indel frequency as mean +/- range of duplicate PCRs. Because T7E1 is semi-quantitative, formal hypothesis testing is limited; for comparing guides, use a one-way ANOVA with Tukey correction across guides (n = 2-3) at alpha = 0.05 with the explicit caveat that estimates are approximate. Where precise quantification or statistical claims are needed, validate by amplicon deep sequencing (the orthogonal gold standard) rather than relying on T7E1 alone.